Yasuyo Ando
Overview
Explore the profile of Yasuyo Ando including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshikawa F, Kumashiro N, Shigiyama F, Miyagi M, Ando Y, Uchino H, et al.
Diabetol Int
. 2022 Jan;
13(1):142-147.
PMID: 35059250
Aim: Diabetes and aging are both well-established risk factors for insomnia. Therefore, we investigated the changes in subjective sleep quality in relation to clinical backgrounds and age in patients with...
2.
Yoshikawa F, Uchino H, Nagashima T, Usui S, Miyagi M, Ando Y, et al.
Diabetol Int
. 2022 Jan;
13(1):124-131.
PMID: 35059248
Aims: To improve glycemic variability (GV) is crucial in the management of multiple daily insulin (MDI) treatment in diabetes. To evaluate the GV improvement in MDI treated type 2 diabetes...
3.
Ando Y, Shigiyama F, Hirose T, Kumashiro N
J Diabetes Investig
. 2021 Mar;
12(10):1816-1826.
PMID: 33650779
Aims/introduction: We investigated the potential use of canagliflozin, in comparison with liraglutide, as an alternative to bolus insulin in patients with well-controlled type 2 diabetes mellitus receiving multiple daily insulin...
4.
Yoshikawa F, Shigiyama F, Ando Y, Miyagi M, Uchino H, Hirose T, et al.
Diabetes Res Clin Pract
. 2020 Sep;
169:108412.
PMID: 32911037
Aims: This study aimed to assess the chronotherapeutic efficacy of suvorexant on subjective sleep parameters and metabolic parameters in patients with type 2 diabetes and insomnia. Methods: Thirteen patients with...
5.
Kanazawa K, Uchino H, Shigiyama F, Igarashi H, Ikehara K, Yoshikawa F, et al.
J Diabetes Investig
. 2018 Dec;
10(4):1022-1031.
PMID: 30582774
Aims/introduction: Hyperglycemia impairs energy substrate oxidation as a result of glucotoxicity. We examined whether the reduction of plasma glucose using a sodium-glucose cotransporter 2 inhibitor, in inpatient diabetes management, has...
6.
Yoshikawa F, Kumashiro N, Shigiyama F, Uchino H, Ando Y, Yoshino H, et al.
Diabetes Obes Metab
. 2018 Sep;
21(2):303-311.
PMID: 30187632
Aims: To explore the effects of intermittent use of empagliflozin, a sodium-glucose co-transporter-2 inhibitor, on dietary self-management and glycaemic control in patients with inadequately controlled type 2 diabetes. Materials And...
7.
Hashimoto A, Yoshino H, Yoshikawa F, Kumashiro N, Ando Y, Yamabe F, et al.
Intern Med
. 2017 Dec;
57(9):1317-1319.
PMID: 29279502
Cavernous hemangioma is a rare, non-functional, benign adrenal tumor. Adrenal cavernous hemangioma is often diagnosed after surgery with a histologic examination. A 70-year-old man complaining of appetite loss was admitted...
8.
Iga R, Uchino H, Kanazawa K, Usui S, Miyagi M, Kumashiro N, et al.
Diabetes Ther
. 2017 May;
8(4):783-792.
PMID: 28547206
Introduction: Optimal adjustment of basal insulin to overcome hypoglycemia and glycemic variability (GV) depends on its duration of action and peak-less profile. Owing to the ability of long-acting basal insulin...
9.
Igarashi H, Yoshino H, Hijikata M, Kumashiro N, Ando Y, Uchino H, et al.
Clin Case Rep
. 2017 May;
5(5):570-573.
PMID: 28469851
Acute suppurative thyroiditis (AST) accompanied by an abscess is a rare clinical case. Hemodialysis patients are at risk for infections. Sepsis mortality was from 100 to 300 times higher for...
10.
Sasaki Y, Nakata K, Suzuki K, Ando Y
BMJ Case Rep
. 2015 Apr;
2015.
PMID: 25858941
Pituitary apoplexy, a syndrome caused by haemorrhage into the pituitary gland, typically manifests as sudden severe headache, visual symptoms and hypopituitarism, including adrenal insufficiency. We report a case of a...